|Bid||2.95 x 100|
|Ask||8.35 x 100|
|Day's Range||7.58 - 7.89|
|52 Week Range||3.21 - 8.00|
|PE Ratio (TTM)||-8.09|
|Earnings Date||Mar 7, 2017 - Mar 13, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||9.83|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spectrum Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SPPI-US. Comparing the performance and risk of Spectrum Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the 42nd Annual Deutsche Bank Health Care Conference being held at The InterContinental Boston Hotel in Boston....
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a teleconference and webcast with management to discuss the first quarter 2017 financial results, provide an update on the Company's business, and discuss expectations for the future.